HUP0900487A2 - 17-acetoxi-11ß-[4-(dimetil-amino)-fenil]-21-metoxi-19-norpregna-4,9-dién-3,20-dion új kristályos polimorf módosulata és eljárás elõállítására - Google Patents
17-acetoxi-11ß-[4-(dimetil-amino)-fenil]-21-metoxi-19-norpregna-4,9-dién-3,20-dion új kristályos polimorf módosulata és eljárás elõállításáraInfo
- Publication number
- HUP0900487A2 HUP0900487A2 HU0900487A HUP0900487A HUP0900487A2 HU P0900487 A2 HUP0900487 A2 HU P0900487A2 HU 0900487 A HU0900487 A HU 0900487A HU P0900487 A HUP0900487 A HU P0900487A HU P0900487 A2 HUP0900487 A2 HU P0900487A2
- Authority
- HU
- Hungary
- Prior art keywords
- acetoxy
- dione
- diene
- dimethylamino
- methoxy
- Prior art date
Links
- 239000013078 crystal Substances 0.000 title 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
- C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0900487A HUP0900487A2 (hu) | 2009-08-05 | 2009-08-05 | 17-acetoxi-11ß-[4-(dimetil-amino)-fenil]-21-metoxi-19-norpregna-4,9-dién-3,20-dion új kristályos polimorf módosulata és eljárás elõállítására |
HUE10747484A HUE025397T2 (hu) | 2009-08-05 | 2010-08-05 | CDB-4124 új kristályos módosulata és eljárás annak elõállítására |
PL10747484T PL2462154T3 (pl) | 2009-08-05 | 2010-08-05 | Nowa krystaliczna postać CDB-4124 i sposób jej wytwarzania |
PCT/HU2010/000088 WO2011015892A2 (en) | 2009-08-05 | 2010-08-05 | Novel crystal form of an organic compound and process for the preparation thereof |
EA201200241A EA019114B1 (ru) | 2009-08-05 | 2010-08-05 | НОВАЯ КРИСТАЛЛИЧЕСКАЯ ФОРМА 17α-АЦЕТОКСИ-21-МЕТОКСИ-11β-[4-N,N-ДИМЕТИЛАМИНОФЕНИЛ]-19-НОРПРЕГНА-4,9-ДИЕН-3,20-ДИОНА И СПОСОБ ЕЁ ПОЛУЧЕНИЯ |
EP10747484.3A EP2462154B1 (en) | 2009-08-05 | 2010-08-05 | Novel crystal form of cdb-4124 and process for the preparation thereof |
ES10747484.3T ES2546098T3 (es) | 2009-08-05 | 2010-08-05 | Nueva forma cristalina del CDB-4124 y proceso para la preparación de la misma |
US13/387,783 US9221870B2 (en) | 2009-08-05 | 2010-08-05 | Crystal form of an organic compound and process for the preparation thereof |
US14/980,302 US20160220585A1 (en) | 2009-08-05 | 2015-12-28 | Novel crystal form of an organic compound and process for the preparation thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0900487A HUP0900487A2 (hu) | 2009-08-05 | 2009-08-05 | 17-acetoxi-11ß-[4-(dimetil-amino)-fenil]-21-metoxi-19-norpregna-4,9-dién-3,20-dion új kristályos polimorf módosulata és eljárás elõállítására |
Publications (2)
Publication Number | Publication Date |
---|---|
HU0900487D0 HU0900487D0 (en) | 2009-09-28 |
HUP0900487A2 true HUP0900487A2 (hu) | 2011-03-28 |
Family
ID=89989159
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0900487A HUP0900487A2 (hu) | 2009-08-05 | 2009-08-05 | 17-acetoxi-11ß-[4-(dimetil-amino)-fenil]-21-metoxi-19-norpregna-4,9-dién-3,20-dion új kristályos polimorf módosulata és eljárás elõállítására |
HUE10747484A HUE025397T2 (hu) | 2009-08-05 | 2010-08-05 | CDB-4124 új kristályos módosulata és eljárás annak elõállítására |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUE10747484A HUE025397T2 (hu) | 2009-08-05 | 2010-08-05 | CDB-4124 új kristályos módosulata és eljárás annak elõállítására |
Country Status (7)
Country | Link |
---|---|
US (2) | US9221870B2 (hu) |
EP (1) | EP2462154B1 (hu) |
EA (1) | EA019114B1 (hu) |
ES (1) | ES2546098T3 (hu) |
HU (2) | HUP0900487A2 (hu) |
PL (1) | PL2462154T3 (hu) |
WO (1) | WO2011015892A2 (hu) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0900171A2 (hu) * | 2009-03-20 | 2010-12-28 | Richter Gedeon Nyrt | 17-acetoxi-11ß-[4-(dimetil-amino)-fenil]-21-metoxi-19-norpregna-4,9-dién-3,20-dion új kristályos módosulata és eljárás elõállítására |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3921059A1 (de) * | 1989-06-23 | 1991-01-10 | Schering Ag | 11(beta)-aryl-4-estrene, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel |
DE4042007A1 (de) * | 1990-12-22 | 1992-06-25 | Schering Ag | 6,7-modifizierte-11(beta)-aryl-4-estrene |
AU710139B2 (en) * | 1996-05-01 | 1999-09-16 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | 21-substituted progesterone derivatives as new antiprogestational agents |
US6900193B1 (en) * | 1996-05-01 | 2005-05-31 | The United States Of America As Represented By The Department Of Health And Human Services | Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents |
US6768014B2 (en) * | 1999-12-29 | 2004-07-27 | The United States Of America As Represented By The Department Of Health And Human Services | PROCESS FOR PREPARING 17α-ACETOXY-11β-[4-N,N(DIMETHYLAMINO)PHENYL]-21-METHOXY-19-NORPREGNA-4,9-DIENE-3,20-DIONE, INTERMEDIATES USEFUL IN THE PROCESS , AND PROCESSES FOR PREPARING SUCH INTERMEDIATES |
ES2546291T3 (es) | 2000-03-17 | 2015-09-22 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | 17-Alfa-sustituida, 11-beta-sustituida-4-arilo y 21-sustituida 19-norpregnadienodionas como agentes antiprogestacionales |
US8044223B2 (en) | 2003-04-04 | 2011-10-25 | Bridge Organics Co. | Crystalline 19-norsteroids |
WO2007103510A2 (en) * | 2006-03-08 | 2007-09-13 | Danco Laboratories Llc | Methods, dosing regimens & medications using anti-progestational agents for the treatment of disorders |
CN101616926A (zh) | 2007-01-17 | 2009-12-30 | 利普生物药剂公司 | 11-(4-氨基苯基)-19-去甲孕-4,9(10)-二烯-3,20-二酮衍生物的可药用盐 |
HU228636B1 (en) | 2007-06-27 | 2013-04-29 | Richter Gedeon Nyrt | Industrial method for the synthesis of 17-acetoxy-11betha-4[-(dimethylamino)-phenyl]-21-methoxy-19-norpregna-4,9-dien-3,20-dione and the key intermediates of the process |
TW201002736A (en) * | 2008-04-28 | 2010-01-16 | Repros Therapeutics Inc | Compositions and methods for treating progesterone-dependent conditions |
TWI477276B (zh) * | 2008-04-28 | 2015-03-21 | Repros Therapeutics Inc | 抗黃體素給藥方案 |
HUP0900171A2 (hu) | 2009-03-20 | 2010-12-28 | Richter Gedeon Nyrt | 17-acetoxi-11ß-[4-(dimetil-amino)-fenil]-21-metoxi-19-norpregna-4,9-dién-3,20-dion új kristályos módosulata és eljárás elõállítására |
-
2009
- 2009-08-05 HU HU0900487A patent/HUP0900487A2/hu unknown
-
2010
- 2010-08-05 PL PL10747484T patent/PL2462154T3/pl unknown
- 2010-08-05 EA EA201200241A patent/EA019114B1/ru not_active IP Right Cessation
- 2010-08-05 WO PCT/HU2010/000088 patent/WO2011015892A2/en active Application Filing
- 2010-08-05 ES ES10747484.3T patent/ES2546098T3/es active Active
- 2010-08-05 EP EP10747484.3A patent/EP2462154B1/en active Active
- 2010-08-05 HU HUE10747484A patent/HUE025397T2/hu unknown
- 2010-08-05 US US13/387,783 patent/US9221870B2/en not_active Expired - Fee Related
-
2015
- 2015-12-28 US US14/980,302 patent/US20160220585A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
HU0900487D0 (en) | 2009-09-28 |
US9221870B2 (en) | 2015-12-29 |
EA201200241A1 (ru) | 2012-07-30 |
US20160220585A1 (en) | 2016-08-04 |
WO2011015892A3 (en) | 2011-03-31 |
US20120142655A1 (en) | 2012-06-07 |
PL2462154T3 (pl) | 2015-12-31 |
HUE025397T2 (hu) | 2016-02-29 |
EA019114B1 (ru) | 2014-01-30 |
EP2462154A2 (en) | 2012-06-13 |
EP2462154B1 (en) | 2015-06-24 |
ES2546098T3 (es) | 2015-09-18 |
WO2011015892A2 (en) | 2011-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20160208T1 (hr) | Polimorfi dasatiniba i postupak za njihovu pripremu | |
EP2479142A4 (en) | POLYCRYSTALLINE SILICON MASS AND PROCESS FOR PRODUCING POLYCRYSTALLINE SILICON MASS | |
EP2464755A4 (en) | METHODS AND KITS FOR MARKING THE 3 'END OF RNA | |
EP2471981A4 (en) | SIC MONOCRYSTAL WAFER AND METHOD FOR MANUFACTURING THE SAME | |
EP2385158A4 (en) | MONOCRYSTAL SILICON CARBIDE AND MONOCRYSTAL SILICON CARBIDE PLATEBOARD | |
EP2309039A4 (en) | Seed cristal for growing silicium carbenedicle cristals, method for making same, and silicon carbyne cristalline, and method for making the same | |
RS55316B1 (sr) | Novi oblik kristalnog vi agomelatina, postupak pripreme i njegove farmaceutske kompozicije | |
AP3049A (en) | New crystalline form VI of agomelatine, preparation method and application thereof | |
PL2318365T3 (pl) | Nowe odmiany polimorficzne (L) argininianu peryndoprylu i sposoby ich wytwarzania | |
IL193089A0 (en) | Process for preparing voriconazole, new polymorphic form of intermediate thereof, and uses thereof | |
EP2271352A4 (en) | COMPOSITIONS AND METHODS FOR TREATING NEOPLASTIC DISEASE | |
IL200387A0 (en) | Heterocylic compounds, compositions comprising them and methods of their use | |
EP2235134A4 (en) | Method of making amidoamine alkoxylates and compounds thereof | |
WO2012107890A3 (en) | Crystal forms of lurasidone chlorhydrate | |
IL219913A0 (en) | New process for the preparation of tapentadol and intermediates thereof | |
ZA201100016B (en) | "crystal of spiroketal derivatives and process for preparation of spiroketal derivatives" | |
IL213177A0 (en) | Crystal forms, methods of preparation, pharmaceutical compositions and uses of nicousamide | |
EP2175856A4 (en) | NOVEL PROCESS FOR THE PREPARATION OF HIGH-PURITY LEVOCETRIXIN AND ITS SALTS | |
EP2479176A4 (en) | PROCESS FOR THE PREPARATION OF ILOPERIDONE AND METHOD FOR ITS CRYSTALLIZATION | |
EP2154138A4 (en) | NOVEL COMPOUNDS FOR THE TREATMENT OF PSYCHOTIC DISORDERS, METHODS OF PREPARATION, AND USES THEREOF | |
IL207557A0 (en) | Process for the preparation of pregnane derivatives | |
EP2285398A4 (en) | METHOD AND COMPOSITIONS FOR TREATING ADIPOSITAS | |
WO2009070311A3 (en) | Crystal forms of o-desmethylvenlafaxine fumarate | |
HUP0900487A2 (hu) | 17-acetoxi-11ß-[4-(dimetil-amino)-fenil]-21-metoxi-19-norpregna-4,9-dién-3,20-dion új kristályos polimorf módosulata és eljárás elõállítására | |
HUP0900171A2 (hu) | 17-acetoxi-11ß-[4-(dimetil-amino)-fenil]-21-metoxi-19-norpregna-4,9-dién-3,20-dion új kristályos módosulata és eljárás elõállítására |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |